cbdMD, Inc.
YCBD · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $5 | $5 |
| % Growth | -3% | -7.1% | 12.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $3 | $3 | $3 | $2 |
| % Margin | 61.5% | 62.3% | 66.5% | 53.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $1 | $1 | $1 | -$0 |
| Operating Expenses | $4 | $3 | $3 | $3 |
| Operating Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -19.6% | -10.2% | -1.7% | -6.9% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$1 | -$0 | $0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | $0 | -$0 |
| % Margin | -19.4% | -31.2% | 0.3% | -3.4% |
| EPS | -0.21 | -19.03 | -0.22 | 1.52 |
| % Growth | 98.9% | -8,550% | -114.5% | – |
| EPS Diluted | -0.21 | -1.9 | -0.22 | 1.52 |
| Weighted Avg Shares Out | 6 | 0 | 5 | 4 |
| Weighted Avg Shares Out Dil | 6 | 8 | 5 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -9.9% | 2% | 4.9% | 6.1% |